Cite
HARVARD Citation
Kameda, T. et al. (n.d.). FRI0056 Serum IL-10 and IP-10 Levels is an Important Predictor of Response to Tocilizumab in Bio-Naïve RA Patients. Annals of the rheumatic diseases. p. 439. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kameda, T. et al. (n.d.). FRI0056 Serum IL-10 and IP-10 Levels is an Important Predictor of Response to Tocilizumab in Bio-Naïve RA Patients. Annals of the rheumatic diseases. p. 439. [Online].